# Stepan Co: Form 10-Q for the period ended Sep 30, 2018

- Company: [Stepan Co](/companies/scl.md) (CIK 94049)
- Form: 10-Q
- Filed: 2018-11-01
- Accepted by EDGAR: Nov 1, 2018, 10:46 ET
- Period: 2018-09-30
- Accession: 0001564590-18-026046
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/94049/000156459018026046/scl-10q_20180930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/94049/000156459018026046/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2018-07-01 to 2018-09-30 | $508.0m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2018-01-01 to 2018-09-30 | $1.53bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2018-07-01 to 2018-09-30 | $423.9m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2018-01-01 to 2018-09-30 | $1.26bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2018-07-01 to 2018-09-30 | $84.1m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2018-01-01 to 2018-09-30 | $263.0m | us-gaap:GrossProfit |
| Operating income | 3 months, 2018-07-01 to 2018-09-30 | $27.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2018-01-01 to 2018-09-30 | $112.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2018-07-01 to 2018-09-30 | $3.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2018-01-01 to 2018-09-30 | $19.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2018-07-01 to 2018-09-30 | $22.2m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2018-01-01 to 2018-09-30 | $85.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2018-07-01 to 2018-09-30 | $0.95 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2018-01-01 to 2018-09-30 | $3.68 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2018-07-01 to 2018-09-30 | $0.96 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2018-01-01 to 2018-09-30 | $3.73 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2018-07-01 to 2018-09-30 | 23,288,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2018-01-01 to 2018-09-30 | 23,324,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2018-01-01 to 2018-09-30 | $96.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2018-01-01 to 2018-09-30 | $62.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2018-01-01 to 2018-09-30 | $15.2m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months, 2018-01-01 to 2018-09-30 | $13.5m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2018-09-30 | $274.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2018-09-30 | $815.0m | us-gaap:AssetsCurrent |
| Total assets | at 2018-09-30 | $1.49bn | us-gaap:Assets |
| Current liabilities | at 2018-09-30 | $326.9m | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2018-09-30 | $262.6m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2018-09-30 | $23.7m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2018-09-30 | $777.7m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 72,189 characters.

The following is management’s discussion and analysis (MD&A) of certain significant factors that have affected the Company’s financial condition and results of operations during the interim periods included in the accompanying condensed consolidated financial statements.

Certain statements in this Quarterly Report on Form 10-Q, other than purely historical information, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act). These statements include statements about Stepan Company’s and its subsidiaries’ (the Company) plans, objectives, strategies, financial performance and outlook, trends, the amount and timing of future cash distributions, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, the Company’s actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, forward-looking statements can be identified by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “guidance,” “predict,” “potential,” “continue,” “likely,” “will,” “would,” “should,” “illustrative” and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by the Company and its management based on their knowledge and understanding of the business and industry, are inherently uncertain. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements. There are a number of risks, uncertainties and other important factors, many of which are beyond the Company’s control, that could cause the Company’s actual results to differ materially from the forward-looking statements contained in this Quarterly Report on Form 10-Q.

Such risks, uncertainties and other important factors, include, among others, the risks, uncertainties and factors set forth under “Part I-Item IA. Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017 inclusive of: (a) the risks and uncertainties related to accidents, unplanned production shutdowns or disruptions in any of the Company’s manufacturing facilities; (b) global competition and the Company’s ability to successfully compete; (c) volatility of raw material, natural gas and electricity costs as well as any disruption in their supply; (d) disruptions in transportation or significant changes in transportation costs; (e) reduced demand for Company products due to customer product reformulations or new technologies; (f) the Company’s ability to make acquisitions of suitable candidates and successfully integrate acquisitions; (g) the Company’s ability to keep and protect its intellectual property rights; (h) international business risks, including fluctuations in currency exchange rates, legal restrictions and taxes; (i) potentially adverse tax consequences due to the international scope of the Company’s operations; (j) the impact of changes in the tax code as a result of recent U.S. federal tax legislation and uncertainty as to how some of those changes may be applied; (k) compliance with anti-corruption, environmental, health and safety and product registration laws; (l) the Company’s inability to accurately estimate and maintain appropriate levels of recorded liabilities for existing and future contingencies; (m) the Company’s ability to operate within the limitations of its debt covenants; (n) downgrades to the Company’s credit ratings or disruptions to the Company’s ability to access well-functioning capital markets; (o) downturns in certain industries and general economic downturns; (p) conflicts, military actions, terrorist attacks and general instability, particularly in certain energy-producing nations, along with increased security regulations; (q) cost overruns, delays and miscalculations in capacity needs with respect to the Company’s expansion or other capital projects; (r) interruption of, damage to or compromise of the Company’s IT systems and failure to maintain the integrity of customer, colleague or Company data; (s) unfavorable resolution of litigation against the Company; (t) and the Company’s ability to retain its executive management and other key personnel.

These factors are not necessarily all of the important factors that could cause the Company’s actual financial results, performance, achievements or prospects to differ materially from those expressed in or implied by any of its forward-looking statements. Other unknown or unpredictable factors also could harm the Company’s results. All forward-looking statements attributable to the Company or persons acting on the Company’s behalf are expressly qualified in their entirety by the cautionary statements set forth above. Forward-looking statements speak only as of the date they are made, and the Company does not undertake or assume any obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If the Company updates one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect to those or other forward-looking statements. The “Company,” “we,” “our” or “us” means Stepan Company and one or more of its subsidiaries only.

### Overview

The Company produces and sells intermediate chemicals that are used in a wide variety of applications worldwide. The overall business comprises three reportable segments:

- Surfactants – Surfactants, which accounted for 70 percent of Company consolidated net sales for the first nine months of 2018, are principal ingredients in consumer and industrial cleaning products such as detergents for washing clothes, dishes, carpets, floors and walls, as well as shampoos and body washes. Other applications include fabric softeners, germicidal quaternary compounds, lubricating ingredients, emulsifiers for spreading agricultural products and industrial applications such as latex systems, plastics and composites. Surfactants are manufactured at five sites in the United States, three European sites (United Kingdom, France and Germany), five Latin American sites (one site in Colombia and two sites in

each of Brazil and Mexico) and two Asian sites (Philippines and Singapore). In 2016, the Company shut down its production facility in Canada, moving the production of goods previously manufactured in Canada to other Company production sites in the United States. Manufacturing operations at that facility ceased in the fourth quarter of 2016 but decommissioning activities were incurred in 2017 and will continue throughout 2018. In March 2018, the Company, through a subsidiary in Mexico, acquired a production facility and a portion of its related surfactant business from BASF Mexicana, S.A. DE C.V. See the “2018 Acquisition” paragraph below for additional details.

- Polymers – Polymers, which accounted for 26 percent of consolidated net sales for the first nine months of 2018, include polyurethane polyols, polyester resins and phthalic anhydride. Polyurethane polyols are used in the manufacture of rigid foam for thermal insulation in the construction industry and are also a base raw material for coatings, adhesives, sealants and elastomers (collectively, CASE products). Powdered polyester resins are used in coating applications. CASE and polyester resins are collectively referred to as specialty polyols. Phthalic anhydride is used in unsaturated polyester resins, alkyd resins and plasticizers for applications in construction materials and components of automotive, boating and other consumer products. In addition, the Company uses phthalic anhydride internally in the production of polyols. In the United States, polyurethane polyols and phthalic anhydride are manufactured at the Company’s Millsdale, Illinois, site and specialty polyols are manufactured at the Company’s Columbus, Georgia, site. In Europe, polyurethane polyols are manufactured by the Company’s subsidiary in Germany, and specialty polyols are manufactured by the Company’s Poland subsidiary. In China, polyurethane polyols and specialty polyols are manufactured at the Company’s Nanjing, China, plant.
- Specialty Products – Specialty products, which accounted for four percent of consolidated net sales for the first nine months of 2018, include flavors, emulsifiers and solubilizers used in food, flavoring, nutritional supplement and pharmaceutical applications. Specialty products are primarily manufactured at the Company’s Maywood, New Jersey, site and, in some instances, at outside contractors.

#### 2018 Acquisition

On March 26, 2018, the Company, through a subsidiary in Mexico, acquired BASF Mexicana, S.A. DE C.V.’s (BASF) production facility in Ecatepec, Mexico, and a portion of its related surfactants business. The facility, which is near Mexico City, has over 50,000 metric tons of capacity, 124,000 square feet of warehouse space, a laboratory and office space. The acquisition supports the Company’s growth strategy in Latin America. The Company believes that this acquisition should enhance its market position and supply capabilities for surfactants in Mexico and position the Company to grow in both the consumer and functional surfactants markets. See Note 16 for additional details.

#### Deferred Compensation Plans

The accounting for the Company’s deferred compensation plans can cause period-to-period fluctuations in Company expenses and profits. Compensation expense results when the values of Company common stock and mutual fund investment assets held for the plans increase, and compensation income results when the values of Company common stock and mutual fund investment assets decline. The pretax effect of all deferred compensation-related activities (including realized and unrealized gains and losses on the mutual fund assets held to fund the deferred compensation obligations) and the income statement line items in which the effects of the activities were recorded are displayed in the following table:

*(In millions)*

|  | Income (Expense) For the Three Months Ended September 30, 2018 | 2017 | Change |  |
| --- | ---: | ---: | ---: | ---: |
| Deferred Compensation (Administrative expenses) | $(4.2) | $0.1 | $(4.3) | (1) |
| Realized/Unrealized Gains on Investments (Other, net) | 0.7 | 1.0 | (0.3) |  |
| Investment Income (Other, net) | 0.1 | 0.1 | — |  |
| Pretax Income Effect | $(3.4) | $1.2 | $(4.6) |  |

*(In millions)*

|  | Income (Expense) For the Nine Months Ended September 30 2018 | 2017 | Change |  |
| --- | ---: | ---: | ---: | ---: |
| Deferred Compensation (Administrative expense) | $(5.0) | $(5.3) | $0.3 | (1) |
| Realized/Unrealized Gains on Investments (Other, net) | 1.2 | 3.5 | (2.3) |  |
| Investment Income (Other, net) | 0.3 | 0.2 | 0.1 |  |
| Pretax Income Effect | $(3.5) | $(1.6) | $(1.9) |  |

(1) See the applicable Corporate Expenses sections of this MD&A for details regarding the changes in deferred compensation expense.

#### Effects of Foreign Currency Translation

The Company’s foreign subsidiaries transact business and report financial results in their respective local currencies. As a result, foreign subsidiary income statements are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period. Because foreign exchange rates fluctuate against the U.S. dollar over time, foreign currency translation affects period-to-period comparisons of financial statement items (i.e., because foreign exchange rates fluctuate, similar period-to-period local currency results for a foreign subsidiary may translate into different U.S. dollar results). The following table presents the effects that foreign currency translation had on the period-over-period changes in consolidated net sales and various income line items for the three and nine months ended September 30, 2018 and 2017:

*(In millions)*

|  | Three Months Ended September 30 2018 | 2017(1) | Increase (Decrease) | Decrease Due to Foreign Translation |
| --- | ---: | ---: | ---: | ---: |
| Net Sales | $508.0 | $487.8 | $20.2 | $(10.7) |
| Gross Profit | 84.1 | 75.6 | 8.5 | (1.7) |
| Operating Income | 27.7 | 30.4 | (2.7) | (1.1) |
| Pretax Income | 25.2 | 29.3 | (4.1) | (0.9) |

*(In millions)*

|  | Nine Months Ended September 30 2018 | 2017 | Increase (Decrease) | Increase Due to Foreign Translation |
| --- | ---: | ---: | ---: | ---: |
| Net Sales | $1,527.2 | $1,451.2 | $76.0 | $11.4 |
| Gross Profit | 263.0 | 257.7 | 5.3 | 0.8 |
| Operating Income | 112.0 | 115.8 | (3.8) | 0.2 |
| Pretax Income | 105.4 | 110.7 | (5.3) | 0.5 |

(1) The 2017 gross profit and operating income line items have been immaterially changed from the amounts originally reported as a result of the Company’s first quarter 2018 adoption of ASU No. 2017-07 *Compensation-Retirement Benefits (Topic 715).*

RESULTS OF OPERATIONS

#### Three Months Ended September 30, 2018 and 2017

### Summary

Net income attributable to the Company for the third quarter of 2018 increased one percent to $22.2 million, or $0.95 per diluted share, from $21.9 million, or $0.94 per diluted share, for the third quarter of 2017. Adjusted net income increased 21 percent to $26.0 million, or $1.11 per diluted share, from $21.4 million, or $0.92 per diluted share, in 2017 (see the “Reconciliation of Non-GAAP Adjusted Net Income and Diluted Earnings per Share” section of this MD&A for a reconciliation between reported net income attributable to the Company and related earnings per diluted share and non-GAAP adjusted net income and related earnings per diluted share). Below is a summary discussion of the major factors leading to the quarter-over-quarter changes in net sales, profits and expenses. A detailed discussion of segment operating performance for the third quarter of 2018 compared to the third quarter of 2017 follows the summary.

Consolidated net sales increased $20.2 million, or four percent in the third quarter of 2018 compared to the third quarter of 2017. The increase was mostly attributable to a six percent increase in sales volume, which favorably impacted the quarter-over-quarter change in net sales by $31.1 million. Most of the sales volume increase related to the Surfactant segment. Foreign currency translation negatively impacted the quarter-over-quarter net sales change by $10.7 million. The unfavorable foreign currency translation effect primarily reflected a stronger U.S. dollar against the Brazilian real, Mexican peso, Philippine peso, European euro and Polish zloty. Lower average selling prices negatively impacted the quarter-over-quarter change in net sales by $0.2 million.

Operating income for the third quarter of 2018 decreased $2.7 million, or nine percent, compared to operating income reported for the third quarter of 2017. Consolidated operating income was negatively impacted by higher 2018 deferred compensation, corporate and business restructuring expenses, which increased by $4.4 million, $3.6 million and $1.3 million quarter-over-quarter, respectively. With respect to the segments, Surfactant and Specialty Product operating income improved by $8.6 million and $1.7 million, respectively, whereas Polymer operating income declined by $3.7 million.

Operating expenses (including deferred compensation and business restructuring expenses) increased $11.3 million, or 25 percent, between quarters. Changes in the individual income statement line items that comprise the Company’s operating expenses were as follows:

- Selling expenses increased $0.9 million, or seven percent, quarter over quarter primarily due to higher bad debt expense.
- Administrative expenses increased $3.4 million, or 19 percent, quarter over quarter primarily due to employee separation costs and higher salaries and incentive-based compensation expense.
- Research, development and technical service (R&D) expenses increased $1.3 million, or 10 percent, quarter over quarter primarily due to higher incentive-based compensation expense.
- Deferred compensation expense increased $4.4 million quarter over quarter, primarily due to a $9.00 per share increase in the market price of Company common stock in the third quarter of 2018 compared to a $3.48 per share decrease in the third quarter of 2017. See the “Overview” and “Segment Results - Corporate Expenses” sections of this MD&A for further details.
- Business restructuring charges totaled $1.7 million in the third quarter of 2018 versus $0.4 million in 2017. The 2018 restructuring charges were comprised of asset and spare part write-downs related to the Company’s decision to cease Surfactant operations in Germany ($1.4 million) and decommissioning costs associated with the Company’s manufacturing facility in Canada that ceased operations in the fourth quarter of 2016 ($0.3 million). The 2017 restructuring charges related solely to decommissioning costs associated with the Canadian plant ($0.4 million).

Net interest expense for the third quarter of 2018 was flat with net interest expense for the third quarter of 2017.

Other, net was $0.3 million of income for the third quarter of 2018 compared to $1.6 million of income for the same period of 2017. The Company recognized $0.8 million of investment income (including realized and unrealized gains and losses) for the Company’s deferred compensation and supplemental defined contribution mutual fund assets in the third quarter of 2018 compared to $1.1 million of income in last year’s third quarter. In addition, the Company reported foreign exchange losses of $0.3 million in the third quarter of 2018 versus $0.6 million of gains in the third quarter of 2017. The Company also reported $0.2 million of net periodic pension cost in the third quarter of 2018 versus $0.1 million of expense in the third quarter of 2017.

The Company’s effective tax rate was 12.2 percent for the third quarter of 2018 compared to 25.4 percent for the third quarter of 2017. The decrease was primarily attributable to a lower U.S. statutory tax rate of 21 percent in the third quarter of 2018 versus 35 percent in the third quarter of 2017. This benefit was partially offset by: (a) certain unfavorable U.S. tax reform changes that became effective on January 1, 2018 (i.e. global intangible low taxed income, non-deductible executive compensation and the repeal of the domestic production activities deduction), and; (b) lower excess tax benefits derived from stock based compensation awards exercised or distributed in the third quarter of 2018 versus the third quarter of 2017. In addition, during the third quarter of 2018, the Company filed applications to automatically change certain tax accounting methods related to the 2017 tax year. These method changes provided a favorable tax benefit that was partially offset by the negative tax impact recognized as a result of the Company’s plan to repatriate approximately $100 million of foreign cash in the fourth quarter of 2018.

### Segment Results

*(Dollars in thousands)*

| Net Sales | For the Three Months Ended September 30 2018 | September 30 2017 | Increase (Decrease) | Percent Change |
| --- | ---: | ---: | ---: | ---: |
| Surfactants | $346,884 | $321,444 | $25,440 | 8 |
| Polymers | 141,646 | 147,754 | (6,108) | -4 |
| Specialty Products | 19,467 | 18,616 | 851 | 5 |
| Total Net Sales | $507,997 | $487,814 | $20,183 | 4 |

27

*(Dollars in thousands)*

| Operating Income | For the Three Months Ended September 30, 2018 | September 30, 2017 | Increase (Decrease) | Percent Change |
| --- | ---: | ---: | ---: | ---: |
| Surfactants | $31,201 | $22,559 | $8,642 | 38 |
| Polymers | 17,431 | 21,146 | (3,715) | -18 |
| Specialty Products | 2,653 | 990 | 1,663 | 168 |
| Segment Operating Income | $51,285 | $44,695 | $6,590 | 15 |
| Corporate Expenses, Excluding Deferred Compensation and Restructuring | 17,654 | 13,964 | 3,690 | 26 |
| Deferred Compensation Expense | 4,222 | (129) | 4,351 | NM |
| Business Restructuring | 1,715 | 426 | 1,289 | 303 |
| Total Operating Income | $27,694 | $30,434 | $(2,740) | -9 |

(1) The 2017 segment and total operating income line items have been immaterially changed from the amounts originally reported as a result of the Company’s first quarter 2018 adoption of ASU No. 2017-07 *Compensation-Retirement Benefits (Topic 715).*

#### Surfactants

Surfactant net sales for the third quarter of 2018 increased $25.4 million, or eight percent, over net sales for the third quarter of 2017. Higher sales volume had a favorable $27.7 million effect on the quarter-over-quarter change in net sales. All global regions experienced sales volume growth. Higher selling prices positively impacted net sales by $7.0 million. The unfavorable effects of foreign currency translation negatively impacted net sales by $9.3 million. A quarter-over-quarter comparison of net sales by region follows:

*(Dollars in thousands)*

| Net Sales | For the Three Months Ended September 30, 2018 | September 30, 2017 | Increase (Decrease) | Percent Change |
| --- | ---: | ---: | ---: | ---: |
| North America | $205,032 | $184,889 | $20,143 | 11 |
| Europe | 68,120 | 69,325 | (1,205) | -2 |
| Latin America | 58,560 | 51,241 | 7,319 | 14 |
| Asia | 15,172 | 15,989 | (817) | -5 |
| Total Surfactants Segment | $346,884 | $321,444 | $25,440 | 8 |

Net sales for North American operations increased 11 percent between quarters. Higher sales volume and selling prices positively impacted the quarter-over-quarter change in net sales by $15.3 million and $5.1 million, respectively. Foreign currency translation negatively impacted the quarter-over-quarter change in net sales by $0.3 million. Sales volume increased eight percent primarily due an increase in sales volume of products used in laundry and cleaning, personal care, agricultural and oilfield applications. Sales volumes of general surfactants to our distribution partners also increased.

Net sales for European operations decreased two percent between quarters. Lower selling prices and the unfavorable effects of foreign currency translation negatively impacted the quarter-over-quarter change in net sales by $1.9 million and $0.6 million, respectively. A two percent growth in sales volume positively impacted the quarter over quarter change in net sales by $1.3 million. A stronger U.S. dollar against the European euro and British pound sterling led to the foreign currency translation effect.

Net sales for Latin American operations increased 14 percent due to a 19 percent increase in sales volume and higher selling prices. These items favorably impacted the quarter-over-quarter change in net sales by $9.5 million and $5.5 million respectively. The higher sales volume is mostly related to the Company’s 2018 first quarter acquisition in Ecatepec, Mexico, partially offset by lower demand and lost commodity business for products used in laundry and cleaning applications in Brazil. The higher selling prices were primarily due to the pass through of increased raw material costs to customers. Foreign currency translation negatively impacted the quarter-over-quarter change in net sales by $7.7 million. The quarter-over-quarter strengthening of the U.S. dollar against the Brazilian real and the Mexican peso accounted for the majority of the unfavorable foreign currency effect.

Net sales for Asian operations decreased five percent primarily due to the negative impact of foreign currency translation and lower selling prices. These items negatively impacted the quarter-over-quarter change in net sales by $0.7 million and $0.6 million, respectively. A weaker Philippine peso relative to the U.S. dollar caused the negative foreign currency translation effect. Sales volume increased three percent which positively impacted the quarter-over-quarter change in net sales by $0.5 million. This sales volume growth was primarily due to the sale of products used in personal care applications.

Surfactant operating income for the third quarter of 2018 increased $8.6 million, or 38 percent, over operating income for the third quarter of 2017. Gross profit increased $10.4 million on improved North American and European results. Operating expenses increased $1.8 million, or eight percent, quarter-over quarter. Quarter-over-quarter comparisons of gross profit by region and total segment operating expenses and operating income follow:

*(Dollars in thousands)*

| Gross Profit and Operating Income | For the Three Months Ended September 30, 2018 | September 30, 2017 | Increase (Decrease) | Percent Change |
| --- | ---: | ---: | ---: | ---: |
| North America | $38,259 | $27,617 | $10,642 | 39 |
| Europe | 7,575 | 6,205 | 1,370 | 22 |
| Latin America | 7,345 | 7,633 | (288) | -4 |
| Asia | 2,613 | 3,900 | (1,287) | -33 |
| Surfactants Segment Gross Profit | $55,792 | $45,355 | $10,437 | 23 |
| Operating Expenses | 24,591 | 22,796 | 1,795 | 8 |
| Surfactants Segment Operating Income | $31,201 | $22,559 | $8,642 | 38 |

(2) The 2017 North America gross profit and the total operating expenses line items have been immaterially changed from the amounts originally reported as a result of the Company’s first quarter 2018 adoption of ASU No. 2017-07 Compensation-Retirement Benefits (Topic 715).

Gross profit for North American operations increased 39 percent, or $10.6 million, between quarters primarily due to higher unit margins and sales volumes. These items positively impacted the quarter-over-quarter change in gross profit by $8.3 million and $2.3 million, respectively. Higher unit margins were primarily due to a more favorable customer and product mix. Higher quarter-over-quarter sales volumes of products used in laundry and cleaning, personal care, agricultural, and oilfield applications and products sold to our distribution partners contributed to the 2018 volume growth.

Gross profit for European operations increased 22 percent, or $1.4 million, between quarters primarily due to improved unit margins. Higher unit margins favorably impacted the quarter-over-quarter change in gross profit by $1.3 million.

Gross profit for Latin American operations decreased four percent, or $0.3 million, quarter over quarter. This decrease was primarily due to the unfavorable impact of foreign currency translation and lower unit margins. The unfavorable foreign currency translation negatively impacted the quarter-over-quarter change in gross profit by $1.4 million. A stronger U.S. dollar against the Brazilian real and the Mexican peso accounted for the majority of the unfavorable foreign currency effect. A 19 percent increase in sales volume, principally driven by the first quarter acquisition in Ecatepec, Mexico favorably impacted the quarter-over-quarter change in gross profit by $1.4 million. The Ecatepec, Mexico acquisition was slightly accretive to Latin American gross profit in the third quarter.

Gross profit for Asian operations decreased 33 percent, or $1.3 million, between quarters, largely due to lower unit margins. Sales volume grew three percent between quarters.

Operating expenses for the Surfactant segment increased $1.8 million, or eight percent, quarter-over-quarter principally due to higher U.S. incentive-based compensation and bad debt expense.

#### Polymers

Polymers net sales for the third quarter of 2018 decreased $6.1 million versus net sales for the same period of 2017. Lower selling prices, the unfavorable impact of foreign currency translation and a one percent decrease in sales volume negatively impacted the quarter-over-quarter change in net sales by $3.8 million, $1.3 million and $1.0 million, respectively. A quarter-over-quarter comparison of net sales by region follows:

*(Dollars in thousands)*

| Net Sales | For the Three Months Ended September 30 2018 | September 30 2017 | Increase (decrease) | Percent change |
| --- | ---: | ---: | ---: | ---: |
| North America | $87,720 | $86,002 | $1,718 | 2 |
| Europe | 45,780 | 53,008 | (7,228) | -14 |
| Asia and Other | 8,146 | 8,744 | (598) | -7 |
| Total Polymers Segment | $141,646 | $147,754 | $(6,108) | -4 |

29

Net sales for North American operations increased two percent between quarters. Sales volume increased three percent which positively impacted the quarter-over-quarter change in net sales by $3.0 million. The higher sales volume primarily reflects quarter-over-quarter growth within polyols used in rigid foam insulation partially offset by lower phthalic anhydride volume. Selling prices decreased one percent, which had a $1.3 million negative effect on the quarter-over-quarter change in net sales.

Net sales for European operations decreased 14 percent. Lower sales volume, selling prices and the negative effects of foreign currency translation negatively impacted the quarter-over-quarter change in net sales by $3.2 million, $3.0 million and $1.0 million, respectively. Sales volume declined six percent for the quarter.

Net sales for Asia and Other operations decreased seven percent quarter over quarter primarily due to a six percent decrease in sales volume and the negative effects of foreign currency translation. These items negatively impacted the change in nets sales by $0.5 million and $0.4 million, respectively. Higher selling prices positively impacted the current year quarter by $0.3 million.

Polymers operating income for the third quarter of 2018 declined $3.7 million, or 18 percent, from operating income for the third quarter of 2017. Gross profit decreased $3.2 million, or 12 percent, primarily due to reduced unit margins in North America and Europe, lower European volume resulting from the lingering effects of the 2017 MDI shortage and the unfavorable impact of foreign currency translation. Operating expenses increased $0.5 million quarter-over-quarter. Quarter-over-quarter comparisons of gross profit by region and total segment operating expenses and operating income follow:

*(Dollars in thousands)*

| Gross Profit and Operating Income | For the Three Months Ended September 30, 2018 | September 30, 2017 | Increase (Decrease) | Percent Change |
| --- | ---: | ---: | ---: | ---: |
| North America | $17,952 | $19,020 | $(1,068) | -6 |
| Europe | 6,606 | 8,683 | (2,077) | -24 |
| Asia and Other | 199 | 278 | (79) | -28 |
| Polymers Segment Gross Profit | $24,757 | $27,981 | $(3,224) | -12 |
| Operating Expenses | 7,326 | 6,835 | 491 | 7 |
| Polymers Segment Operating Income | $17,431 | $21,146 | $(3,715) | -18 |

(1) The 2017 North America gross profit and the total operating expenses line items have been immaterially changed from the amounts originally reported as a result of the Company’s first quarter 2018 adoption of ASU No. 2017-07 *Compensation-Retirement Benefits (Topic 715).*

Gross profit for North American operations declined six percent quarter over quarter primarily due to reduced unit margins. The reduced margins negatively impacted the quarter-over-quarter change in gross profit by $1.7 million and primarily reflect higher raw material costs that, due to competitive reasons, could not entirely be passed on to customers. A three percent increase in sales volume positively impacted the quarter-over-quarter change in gross profit by $0.6 million. The volume growth primarily reflects quarter-over-quarter growth within polyols used in rigid foam insulation, which was up 13 percent, partially offset by lower phthalic anhydride and specialty polyols volume.

Gross profit for European operations decreased 24 percent due to lower unit margins, a six percent decrease in volume and the unfavorable effects of foreign currency translation. These items negatively impacted the quarter-over-quarter change in gross profit by $1.4 million, $0.6 million and $0.1 million, respectively. The lower unit margins reflect higher raw material costs that, due to competitive reasons, could not entirely be passed on to customers.

Gross profit for Asia and Other operations decreased $0.1 million quarter-over-quarter.

Operating expenses for the Polymer segment increased $0.5 million, or seven percent, quarter-over-quarter principally due to higher U.S. incentive-based compensation and bad debt expense.

#### Specialty Products

Net sales for the third quarter of 2018 increased $0.9 million, or five percent, from net sales for the third quarter of 2017. Higher sales volume led to the net sales increase. Operating income increased $1.7 million quarter-over-quarter. The increase in operating income was primarily due to a more favorable sales mix, mostly attributable to the partial catch up of order timing shortfalls encountered in the first half of the year within the pharmaceutical and flavoring businesses.

#### Corporate Expenses

Corporate expenses, which are comprised of deferred compensation, business restructuring and other operating expenses that are not allocated to the reportable segments, increased $9.3 million between quarters. Corporate expenses were $23.6 million in the third quarter of 2018 versus $14.3 million in 2017. The increase was primarily attributable to deferred compensation expense of $4.2 million recorded in the third quarter of 2018 versus deferred compensation income of $0.1 million recorded a year ago. Higher employee separation costs and business restructuring expense negatively impacted the quarter-over-quarter change in corporate expenses by $3.4 million. Higher salaries and incentive-based compensation costs accounted for most of the remaining variance.

The $4.4 million increase in deferred compensation expense primarily reflected a $9.00 per share increase in the value of Company common stock in the third quarter of 2018 compared to a $3.48 per share decrease for the third quarter of 2017. The following table presents the quarter-end Company common stock market prices used in the computation of deferred compensation expenses for the three months ended September 30, 2018 and 2017:

|  | 2018 September 30 | June 30 | 2017 September 30 | June 30 |
| --- | ---: | ---: | ---: | ---: |
| Company Common Stock Price | $87.01 | $78.01 | $83.66 | $87.14 |

#### Nine Months Ended September 30, 2018 and 2017

### Summary

Net income attributable to the Company for the first nine months of 2018 increased five percent to $85.8 million, or $3.68 per diluted share, from $81.7 million, or $3.50 per diluted share, for the first nine months of 2017. Adjusted net income increased seven percent to $90.1 million, or $3.86 per diluted share, from $84.0 million, or $3.60 per diluted share (see the “Reconciliation of Non-GAAP Adjusted Net Income and Diluted Earnings per Share” section of this MD&A for reconciliations between reported net income attributable to the Company and related earnings per diluted share and non-GAAP adjusted net income and related earnings per diluted share). Below is a summary discussion of the major factors leading to the year-over-year changes in net sales, profits and expenses. A detailed discussion of segment operating performance for the first nine months of 2018 compared to the first nine months of 2017 follows the summary.

Consolidated net sales increased $76.0 million, or five percent, between years. Higher sales volume, the favorable impact of foreign currency translation and higher selling prices positively impacted net sales by $61.2 million, $11.4 million and $3.4 million respectively. Total Company sales volume increased four percent. Sales volume in the Surfactant segment increased six percent while sales volume in the Polymer segment declined three percent. Specialty Product segment sales volume was flat with the prior year. The favorable foreign currency translation effect primarily reflected a weaker U.S. dollar against the European currencies for countries where the Company has foreign operations, partially offset by a stronger U.S. dollar against the Brazil real, Mexican peso and Philippine peso.

Operating income for the first nine months of 2018 declined $3.8 million, or three percent, from operating income reported for the first nine months of 2017. Surfactant operating income improved year-over-year but was more than offset by a decline in Polymer and Specialty Products results and higher corporate expenses.

Operating expenses (including deferred compensation and business restructuring expenses) increased $9.1 million, or six percent, between years. Changes in the individual income statement line items that comprise the Company’s operating expenses were as follows:

- Selling expenses increased $2.5 million, or six percent, year-over-year largely due to higher salaries and incentive-based compensation expense, cloud-based application expense, legal and consulting fees and bad debt expense.
- Administrative expenses increased $5.3 million, or 10 percent, year-over-year primarily due to higher employee separation costs, salaries and incentive-based compensation expense, employee relocation expense and legal expense.
- R&D expenses increased $1.0 million, or three percent, year-over-year.
- Deferred compensation expense decreased $0.3 million, or six percent, year-over-year. See the “Overview” and “Segment Results - Corporate Expenses” sections of this MD&A for further details.
- Business restructuring expenses were $2.3 million in the first nine months of 2018 compared to $1.8 million in the first nine months of 2017. The 2018 restructuring charges were comprised of asset and spare part write-downs related the Company’s decision to cease Surfactant operations in Germany ($1.4 million) and decommissioning costs associated with the Company’s manufacturing facility in Canada which ceased operations in the fourth quarter of 2016 ($0.9 million). The 2017 restructuring charges related to decommissioning costs associated with the Canadian plant ($1.7 million) and workforce reduction expense at the Company’s Singapore plant ($0.1 million). See Note 15 to the condensed consolidated financial statements for additional information regarding the Company’s restructuring activities.

Net interest expense for the first nine months of 2018 was flat with net interest expense for the first nine months of 2017.

Other, net was $2.0 million of income for the first nine months of 2018 compared to $3.5 million of income for the same period of 2017. The Company recognized $1.6 million of investment gains (including realized and unrealized gains and losses) for the Company’s deferred compensation and supplemental defined contribution mutual fund assets in the first nine months of 2018 compared to $3.9 million of investment gains in the first nine months of 2017. In addition, the Company reported foreign exchange gains of $0.9 million in the first nine months of 2018 compared to foreign exchange gains of $0.1 million in the first nine months of 2017. The Company also reported $0.5 million of net periodic pension cost in both the first nine months of 2018 and 2017.

The Company’s effective tax rate was 18.6 percent for the first nine months of 2018 compared to 26.2 percent for the first nine months of 2017. The decrease was primarily attributable to a lower U.S. statutory tax rate of 21 percent in 2018 versus a rate of 35 percent in 2017. This benefit was partially offset by certain unfavorable U.S. tax reform changes that became effective on January 1, 2018 (i.e. global intangible low taxed income, non-deductible executive compensation and the repeal of the domestic production activities deduction). In addition, during the third quarter of 2018, the Company filed applications to automatically change certain tax accounting methods related to the 2017 tax year. These method changes provided a favorable tax benefit that was partially offset by the negative tax impact recognized as a result of the Company’s plan to repatriate approximately $100 million of foreign cash in the fourth quarter of 2018.

### Segment Results

*(In thousands)*

| Net Sales | For the Nine Months Ended September 30, 2018 | September 30, 2017 | Increase (Decrease) | Percent Change |
| --- | ---: | ---: | ---: | ---: |
| Surfactants | $1,062,708 | $973,381 | $89,327 | 9 |
| Polymers | 404,446 | 415,551 | (11,105) | -3 |
| Specialty Products | 60,044 | 62,252 | (2,208) | -4 |
| Total Net Sales | $1,527,198 | $1,451,184 | $76,014 | 5 |

*(In thousands)*

| Operating Income | For the Nine Months Ended September 30, 2018 | September 30, 2017 | Increase (Decrease) | Percent Change |
| --- | ---: | ---: | ---: | ---: |
| Surfactants | $105,670 | $92,080 | $13,590 | 15 |
| Polymers | 53,783 | 63,884 | (10,101) | -16 |
| Specialty Products | 6,543 | 7,711 | (1,168) | -15 |
| Segment Operating Income | $165,996 | $163,675 | $2,321 | 1 |
| Corporate Expenses, Excluding Deferred Compensation and Restructuring | $46,645 | $40,817 | $5,828 | 14 |
| Deferred Compensation Expense (Income) | 4,971 | 5,263 | (292) | -6 |
| Business Restructuring | 2,346 | 1,798 | 548 | 30 |
| Total Corporate Expenses | $53,962 | $47,878 | $6,084 | 13 |
| Total Operating Income | $112,034 | $115,797 | $(3,763) | -3 |

(1) The 2017 segment and total operating income line items have been immaterially changed from the amounts originally reported as a result of the Company’s first quarter 2018 adoption of ASU No. 2017-07 *Compensation-Retirement Benefits (Topic 715).*

#### Surfactants

Surfactant net sales for the first nine months of 2018 increased $89.3 million, or nine percent, over net sales for the first nine months of 2017. Higher sales volume, increased selling prices, and the favorable effects of foreign currency translation positively impacted the year-over-year change in net sales by $62.6 million, $24.8 million and $1.9 million, respectively. Sales volume increased six percent year-over-year. A year-over-year comparison of net sales by region follows:

*(In thousands)*

|  | For the Nine Months Ended September 30, 2018 | September 30, 2017 | Increase (Decrease) | Percent Change |
| --- | ---: | ---: | ---: | ---: |
| North America | $643,466 | $582,148 | $61,318 | 11 |
| Europe | 212,556 | 198,037 | 14,519 | 7 |
| Latin America | 156,827 | 143,305 | 13,522 | 9 |
| Asia | 49,859 | 49,891 | (32) | 0 |
| Total Surfactants Segment | $1,062,708 | $973,381 | $89,327 | 9 |

Net sales for North American operations increased 11 percent year-over-year. Sales volume increased seven percent which favorably impacted the change in net sales by $43.4 million. The sales volume growth was largely driven by higher sales volume of products used in laundry and cleaning, personal care, agricultural and oilfield applications. Sales volumes of general surfactants to our distribution partners also increased. Average selling prices increased three percent between years and positively impacted the year-over-year change in net sales by $17.5 million. The increase in selling prices reflects the pass through of certain higher raw material costs to customers and a more favorable mix of sales. Foreign currency translation positively impacted the change in net sales by $0.4 million. The foreign currency impact reflected a weaker U.S. dollar relative to the Canadian dollar.

Net sales for European operations increased seven percent due to the favorable effects of foreign currency translation and a two percent increase in sales volume. These two items positively impacted the year-over-year change in net sales by $14.1 million and $4.2 million, respectively. A weaker U.S. dollar relative to the British pound sterling and European euro led to the foreign currency translation effect. Lower selling prices of two percent unfavorably impacted the year-over-year change in net sales by $3.8 million.

Net sales for Latin American operations increased nine percent due to higher selling prices and an eight percent increase in sales volume. These two items accounted for $12.3 million and $11.8 million, respectively, of the year-over-year increase in net sales. The higher selling prices primarily reflect the pass through to customers of increased raw material costs. The higher volume is mostly related to the Company’s first quarter acquisition in Ecatepec, Mexico partially offset by lower demand and lost commodity business in Brazil. Foreign currency translation negatively impacted the year-over-year change in net sales by $10.6 million. The foreign currency translation effect primarily reflects the year-over-year weakening of the Brazilian real and Mexican peso relative to the U.S. dollar.

Net sales for Asian operations were flat with prior year. Asia recognized a five percent increase in sales volume which positively impacted the year-over-year change in net sales by $2.5 million. The sales volume increase was mostly due to higher sales of general surfactants to our distribution partners. The unfavorable effects of foreign currency translation and lower selling prices negatively impacted the net sales change by $1.9 million and $0.6 million, respectively. The foreign currency impact primarily reflected a weaker Philippine peso relative to the U.S. dollar.

Surfactant operating income for the first nine months of 2018 increased $13.6 million, or 15 percent, over operating income for the first nine months of 2017. Gross profit increased $17.1 million, primarily due to improved results for North American and European operations. Operating expenses increased $3.5 million, or five percent. Year-over-year comparisons of gross profit by region and total segment operating expenses and operating income follow:

*(In thousands)*

| Gross Profit | For the Nine Months Ended September 30, 2018 | September 30, 2017 | Increase (Decrease) | Percent Change |
| --- | ---: | ---: | ---: | ---: |
| North America | $122,537 | $107,729 | $14,808 | 14 |
| Europe | 24,060 | 18,018 | 6,042 | 34 |
| Latin America | 18,206 | 22,567 | (4,361) | -19 |
| Asia | 13,031 | 12,434 | 597 | 5 |
| Surfactants Segment Gross Profit | $177,834 | $160,748 | $17,086 | 11 |
| Operating Expenses | 72,164 | 68,668 | 3,496 | 5 |
| Operating Income | $105,670 | $92,080 | $13,590 | 15 |

(1) The 2017 North America gross profit and the total operating expenses line items have been immaterially changed from the amounts originally reported as a result of the Company’s first quarter 2018 adoption of ASU No. 2017-07 *Compensation-Retirement Benefits (Topic 715).*

Gross profit for North American operations increased 14 percent, or $14.8 million, between years primarily due to higher sales volumes and unit margins. These items positively impacted the year-over-year change in gross profit by $8.0 million and $6.8 million, respectively. The higher unit margins were primarily due to a more favorable customer and product mix. Higher year-over-year sales of products used in laundry and cleaning, personal care, agricultural, and oilfield applications and products sold to our distribution partners contributed to the 2018 volume growth.

Gross profit for European operations increased 34 percent, or $6.0 million, year-over-year due to higher unit margins, the favorable effect of foreign currency translation and a two percent increase in sales volume. These items favorably impacted the change in year-over-year gross profit by $4.0 million, $1.6 million and $0.4 million, respectively.

Gross profit for Latin American operations decreased 19 percent, or $4.4 million, year-over-year primarily due to lower unit margins and the negative impact of foreign currency translation. These items unfavorably impacted the change in year-over-year gross profit by $4.3 million and $1.9 million, respectively. The lower unit margins principally related to higher integration and start-up costs associated with the Company’s first quarter 2018 acquisition in Ecatepec, Mexico. Sales volume growth of eight percent positively impacted current year gross profit by $1.8 million. This growth primarily reflects the Company’s first quarter acquisition in Ecatepec, Mexico partially offset by lower demand and lost commodity business in Brazil. The Ecatepec, Mexico acquisition had a slightly negative impact on Latin American gross profit for first nine months of 2018.

Gross profit for Asian operations increased five percent, or $0.6 million, largely due to a five percent increase in sales volume and higher year-over-year production volume in Singapore, which led to lower unit overhead costs.

Operating expenses for the Surfactant segment increased $3.5 million, or five percent, year-over-year. Most of this increase was due to higher consulting fees, bad debt expense, salaries and incentive-based compensation expense.

#### Polymers

Polymer net sales for the first nine months of 2018 decreased $11.1 million, or three percent, over net sales for the same period of 2017. Lower sales volumes and selling prices negatively impacted the year-over-year change in net sales by $11.1 million and $8.8 million, respectively. The favorable effects of foreign currency translation positively impacted the year-over-year change in net sales by $8.8 million. A year-over-year comparison of net sales by region follows:

*(Dollars in thousands)*

| Net Sales | For the Nine Months Ended September 30, 2018 | September 30, 2017 | Increase (decrease) | Percent change |
| --- | ---: | ---: | ---: | ---: |
| North America | $248,160 | $251,291 | $(3,131) | -1 |
| Europe | 132,592 | 142,265 | (9,673) | -7 |
| Asia and Other | 23,694 | 21,995 | 1,699 | 8 |
| Total Polymers Segment | $404,446 | $415,551 | $(11,105) | -3 |

Net sales for North American operations declined one percent primarily due to a sales volume decline of one percent and lower selling prices. These items negatively impacted the year-over-year change in net sales by $2.3 million and $0.8 million, respectively. Sales volume of polyols used in rigid foam applications was down mainly due to lost market share during the first half of the year. Sales volume of specialty polyols increased year-over-year.

Net sales for European operations decreased seven percent primarily due to a seven percent decline in sales volume and lower selling prices which negatively impacted the year-over-year change in net sales by $9.5 million and $8.4 million, respectively. The lower volume was principally due to customer inventory builds prior to end of 2017, the carryover effect of the 2017 MDI shortage and extended winter weather which delayed the start of construction projects. The effects of foreign currency translation positively impacted the year-over-year change in net sales by $8.2 million.

Net sales for Asia and Other operations increased eight percent year-over-year primarily due a four percent increase in sales volume, the favorable effects of foreign currency translation and higher selling prices. These items positively impacted the change in net sales by $0.9 million, $0.6 million and $0.2 million, respectively.

Polymer operating income for the first nine months of 2018 declined $10.1 million, or 16 percent, from operating income for the first nine months of 2017. Gross profit decreased $9.6 million, or 11 percent, primarily due to a three percent decline in sales volumes and lower unit margins. Operating expenses were up two percent year-over-year. Year-over-year comparisons of gross profit by region and total segment operating expenses and operating income follow:

*(In thousands)*

| Gross Profit and Operating Income | September 30, 2018 | September 30, 2017 | Increase (Decrease) | Percent Change |
| --- | ---: | ---: | ---: | ---: |
| North America | $54,988 | $61,684 | $(6,696) | -11 |
| Europe | 19,520 | 23,249 | (3,729) | -16 |
| Asia and Other | 845 | 41 | 804 | NM |
| Polymers Segment Gross Profit | $75,353 | $84,974 | $(9,621) | -11 |
| Operating Expenses | 21,570 | 21,090 | 480 | 2 |
| Polymers Segment Operating Income | $53,783 | $63,884 | $(10,101) | -16 |

(1) The 2017 North America gross profit and the total operating expenses line items have been immaterially changed from the amounts originally reported as a result of the Company’s first quarter 2018 adoption of ASU No. 2017-07 *Compensation-Retirement Benefits (Topic 715).*

Gross profit for North American operations declined 11 percent year-over-year primarily due to lower unit margins and the one percent decline in sales volume. These two items negatively impacted the year-over-year change in gross profit by $6.1 million and $0.6 million, respectively.

Gross profit for European operations declined 16 percent primarily due to lower unit sales margins arising from increased raw material costs that could not be entirely passed through to customers and the seven percent decline in sales volume. These items negatively impacted the year-over-year change in gross profit by $3.4 million and $1.5 million, respectively. The favorable impact of foreign currency translation positively impacted the year-over-year change in gross profit by $1.2 million.

Gross profit for Asia and Other operations improved $0.8 million primarily due to higher unit margins and the favorable impact of foreign currency translation. These items positively impacted the year-over-year change in gross profit by $0.7 million and $0.1 million, respectively.

#### Specialty Products

Net sales for the first nine months of 2018 declined $2.2 million over net sales for the same period of 2017. Sales volume was flat year-over-year. Operating income decreased $1.2 million year-over-year principally due to a lower unit margins in the food and nutritional business and a less favorable product mix in the first nine months due to order timing differences in the pharmaceutical and flavoring businesses.

#### Corporate Expenses

Corporate expenses increased $6.1 million to $54.0 million for the first nine months of 2018 versus $47.9 million for the first nine months of 2017. The increase was mostly attributable to higher 2018 employee separation costs, salaries and incentive-based compensation expense, employee relocation expense, legal expense and business restructuring expense. Lower consulting fees incurred in 2018 versus 2017 partially offset the above increases.

Deferred compensation expense decreased $0.3 million, or six percent, between years. The lower expense in 2018 was primarily due to lower mutual fund expense incurred in the current year and fewer Company shares held in the deferred plan in 2018 versus 2017. The following table presents the period-end Company common stock market prices used in the computation of deferred compensation expenses for the nine months ended September 30, 2018 and 2017:

|  | 2018 September 30 | 2017 December 31 | September 30 | 2016 December 31 |
| --- | ---: | ---: | ---: | ---: |
| Company Common Stock Price | $87.01 | $78.97 | $83.66 | $81.48 |

35

LIQUIDITY AND CAPITAL RESOURCES

#### Overview

For the nine months ended September 30, 2018, operating activities were a cash source of $96.2 million versus a source of $124.7 million for the comparable period in 2017. For the current year, investing activities were a use of $82.7 million, as compared to a use of $63.0 million in the prior year period, and financing activities were a use of $34.1 million, as compared to a use of $29.9 million in the prior year period. Cash and cash equivalents decreased by $24.9 million compared to December 31, 2017, including an unfavorable exchange rate impact of $4.3 million.

As of September 30, 2018, the Company’s cash and cash equivalents totaled $274.0 million. Cash in U.S. demand deposit accounts and money market funds totaled $64.7 million and $29.1 million, respectively The Company’s non-U.S. subsidiaries held $180.2 million of cash outside the U.S. as of September 30, 2018.

#### Operating Activity

Net income increased by $4.1 million versus the comparable period in 2017. Working capital was a cash use of $62.6 million versus a use of $29.4 million for the comparable year-ago period.

Year-to-date accounts receivable were a use of $34.8 million compared to a use of $37.7 million for the comparable period in 2017. Inventories were a use of $21.6 million in 2018 versus a source of $14.8 million in 2017. Accounts payable and accrued liabilities were a use of $6.9 million in 2018 compared to a use of $5.9 million for the same period in 2017.

Working capital requirements were higher year-to-date, compared to the same period in 2017, primarily due to the changes noted above. The 2018 accounts receivable increase was primarily due to higher Surfactant sales volume and selling prices. The current year inventory increase was primarily due to higher quantities resulting from the first quarter 2018 acquisition in Ecatepec, Mexico and planned inventory builds in advance of the Company’s 2018 fourth quarter phthalic anhydride maintenance turnaround at the Company’s Millsdale, Illinois site. It is management’s opinion that the Company’s liquidity is sufficient to provide for any additional increases in working capital requirements for the remainder of 2018.

#### Investing Activity

Cash used for investing activities increased by $19.7 million year-over-year. Cash used for investing activities year-to-date included capital expenditures of $62.9 million compared to $57.9 million for the comparable period last year. Other investing activities were a use of $19.8 million in 2018 versus a use of $5.1 million in 2017. The increase in other investing activities was primarily attributable to a use of $21.5 million cash related to the acquisition of BASF’s surfactant production facility in Ecatepec, Mexico and a portion of their related surfactant business during the first quarter of 2018.

For 2018, the Company estimates that total capital expenditures will range from $90 million to $100 million inclusive of infrastructure and optimization spending in the United States, Germany and Mexico.

#### Financing Activity

Cash used for financing activities was a use of $34.1 million in 2018 versus a use of $29.9 million in 2017. The Company purchases shares of its common stock in the open market or from its benefit plans from time to time to fund its own benefit plans and also to mitigate the dilutive effect of new shares issued under its benefit plans. The Company may, from time to time, seek to retire or purchase additional amounts of its outstanding equity and/or debt securities through cash purchases and/or exchanges for other securities, in open market purchases, privately negotiated transactions or otherwise, including pursuant to plans meeting the requirements of Rule 10b5-1 promulgated by the SEC. Such repurchases or exchanges, if any, will depend on prevailing market conditions, the Company’s liquidity requirements, contractual restrictions and other factors. The amounts involved may be material. For the nine months ended September 30, 2018, the Company purchased 179,995 shares in the open market and from its benefit plans at a total cost of $13.5 million. At September 30, 2018, there were 520,275 shares remaining under the current share repurchase authorization.

#### Debt and Credit Facilities

Consolidated balance sheet debt decreased by $4.6 million during the first half of 2018 compared to December 31, 2017. Consolidated balance sheet debt was $286.2 million at September 30, 2018 versus $290.8 million at December 31, 2017. Net debt (which is defined as total debt minus cash – see the “Reconciliation of Non-GAAP Net Debt” section of this MD&A) increased by $20.3 million in the current year, from a negative $8.1 million to a positive $12.2 million, primarily due to a $24.9 million decrease of cash between December 31, 2017 and September 30, 2018.

As of September 30, 2018, the ratio of total debt to total debt plus shareholders’ equity was 26.9 percent compared to 28.2 percent at December 31, 2017. As of September 30, 2018, the ratio of net debt to net debt plus shareholders’ equity was 1.6 percent, compared to a negative 1.1 percent at December 31, 2017. At September 30, 2018, the Company’s debt included $283.3 million of unsecured private placement loans with maturities ranging from 2018 through 2027. These loans are the Company’s primary source of long-term debt financing and are supplemented by bank credit facilities to meet short and medium-term needs.

On January 30, 2018, the Company entered into a five year committed $350 million multi-currency revolving credit facility that matures on January 30, 2023 with a syndicate of banks. This revolving credit facility replaced the Company’s prior $125 million credit agreement. The Company’s outstanding Note Purchase Agreements were amended effective January 30, 2018 to make certain covenants consistent with those included in the revolving credit agreement. As of September 30, 2018, the Company had outstanding letters of credit totaling $5 million under the revolving credit agreement and no outstanding debt under the agreement. There was $345 million available under the revolving credit agreement as of September 30, 2018.

The Company anticipates that cash from operations, committed credit facilities and cash on hand will be sufficient to fund anticipated capital expenditures, working capital, dividends and other planned financial commitments for the foreseeable future.

Certain foreign subsidiaries of the Company maintain short-term bank lines of credit in their respective local currencies to meet working capital requirements as well as to fund capital expenditure programs and acquisitions. At September 30, 2018, the Company’s foreign subsidiaries had outstanding debt of $3.0 million.

The Company has material debt agreements that require the maintenance of minimum interest coverage and minimum net worth. These agreements also limit the incurrence of additional debt as well as the payment of dividends and repurchase of treasury shares. As of September 30, 2018, testing for these agreements was based on the Company’s consolidated financial statements. Under the most restrictive of these debt covenants:

1\. The Company is required to maintain a minimum interest coverage ratio, as defined within the agreements, of 3.50 to 1.00, for the preceding four calendar quarters.

2\. The Company is required to maintain a maximum net leverage ratio, as defined within the agreements, not to exceed 3.50 to 1.00.

3\. The Company is required to maintain net worth of at least $325.0 million.

4\. The Company is permitted to pay dividends and purchase treasury shares after December 31, 2017, in amounts of up to $100.0 million plus 100 percent of net income and cash proceeds of stock option exercises, measured cumulatively beginning December 31, 2017. The maximum amount of dividends that could have been paid within this limitation is disclosed as unrestricted retained earnings in Note 13 to the condensed consolidated financial statements.

The Company believes it was in compliance with all of its loan agreements as of September 30, 2018.

#### ENVIRONMENTAL AND LEGAL MATTERS

The Company’s operations are subject to extensive federal, state and local environmental laws and regulations and similar laws in the other countries in which the Company does business. Although the Company's environmental policies and practices are designed to ensure compliance with these laws and regulations, future developments and increasingly stringent environmental regulation may require the Company to make additional environmental expenditures. The Company will continue to invest in the equipment and facilities necessary to comply with existing and future regulations. For the nine months ended September 30, 2018 and 2017, the Company’s expenditures for capital projects related to the environment were $3.1 million and $1.8 million, respectively. These projects are capitalized and depreciated over their estimated useful lives, which are typically 10 years. Recurring costs associated with the operation and maintenance of facilities for waste treatment and disposal and managing environmental compliance in ongoing operations at the Company’s manufacturing locations were $21.1 million and $20.3 million for the nine months ended September 30, 2018 and 2017, respectively.

Over the years, the Company has received requests for information related to or has been named by the government as a potentially responsible party at a number of waste disposal sites where cleanup costs have been or may be incurred under CERCLA and similar state or foreign statutes. In addition, damages are being claimed against the Company in general liability actions for alleged personal injury or property damage in the case of some disposal and plant sites. The Company believes that it has made adequate provisions for the costs it may incur with respect to the sites and in other commercial disputes. It is the Company’s accounting policy to record liabilities when environmental assessments and/or remedial efforts are probable and the cost or range of possible costs can be reasonably estimated. When no amount within the range is a better estimate than any other amount, the minimum is accrued. Some of the factors on which the Company bases its estimates include information provided by feasibility studies, potentially responsible party negotiations and the development of remedial action plans. After partial remediation payments at certain sites, the Company has estimated a range of possible environmental and legal losses of $24.0 million to $45.5 million at September 30, 2018, compared to $24.2 million to $45.4 million at December 31, 2017. At September 30, 2018, and December 31, 2017, the Company's accrued liability for such losses, which represented the Company’s best estimate within the estimated range of possible environmental and legal losses, was $24.0 million and $24.2 million, respectively. Because the liabilities accrued are estimates, actual amounts could differ from the amounts reported. During the nine-month period ended September 30, 2018 and September 30, 2017, cash outlays related to legal and environmental matters approximated $1.0 million and $1.4 million, respectively.

For certain sites, the Company has responded to information requests made by federal, state or local government agencies but has received no response confirming or denying the Company’s stated positions. As such, estimates of the total costs, or range of possible costs, of remediation, if any, or the Company’s share of such costs, if any, cannot be determined with respect to these sites. Consequently, the Company is unable to predict the effect thereof on the Company’s financial position, cash flows and results of operations. Given the information available, management believes the Company has no liability at these sites. However, in the event of one or more adverse determinations with respect to such sites in any annual or interim period, the effect on the Company’s cash flows and results of operations for those periods could be material. Based upon the Company’s present knowledge with respect to its involvement at these sites, the possibility of other viable entities’ responsibilities for cleanup, and the extended period over which any costs would be incurred, the Company believes that these matters, individually and in the aggregate, will not have a material effect on the Company’s financial position. Certain of these matters are discussed in Item 1, Part 2, Legal Proceedings, in this report and in other filings of the Company with the SEC, which are available upon request from the Company. See also Note 7 to the condensed consolidated financial statements for a summary of the environmental proceedings related to certain environmental sites.

#### OUTLOOK

The Company believes Surfactants will continue to benefit from its diversification efforts into functional products, new technologies, improved internal efficiencies and expanded sales into a broad customer base globally. The Company believes Polymers will continue to benefit from the growing market for insulation materials despite margin challenges with the North American Polymer business. The Company believes full year Specialty Product results should improve versus the prior year. Overall, the Company remains optimistic about delivering full year earnings growth.

#### CRITICAL ACCOUNTING POLICIES

There have been no changes to the critical accounting policies disclosed in the Company’s 2017 Annual Report on Form 10-K with the exception of revenue recognition. During the first quarter of 2018 the Company adopted ASU 2014-19 which changed the criteria for revenue recognition to the time when the Company satisfies its performance obligation by transferring control of product to a customer as compared to the “risk and rewards” criteria used in prior years. Adoption of ASU 2014-19 did not have a material impact on the Company’s financial position as of September 30, 2018 or results of operations for the three and nine months ended September 30, 2018 and 2017. See Note 12 for additional details.

#### RECONCILIATION OF NON-GAAP ADJUSTED NET INCOME AND DILUTED EARNINGS PER SHARE

*(In millions, except per share amounts)*

|  | Three Months Ended September 30 2018 Net Income | Diluted EPS | 2017 Net Income | Diluted EPS |
| --- | ---: | ---: | ---: | ---: |
| **Net Income Attributable to the Company as Reported** | **$22.2** | **$0.95** | **$21.9** | **$0.94** |
| Deferred Compensation (Income) Expense (including related investment activity) | 3.4 | 0.10 | (1.2) | (0.06) |
| Business Restructuring | 1.7 | 0.07 | 0.4 | 0.02 |
| Cumulative Tax Effect on Above Adjustment Items | (1.3) | (0.01) | 0.3 | 0.02 |
| Adjusted Net Income | $26.0 | $1.11 | $21.4 | $0.92 |

38

*(In millions, except per share amounts)*

|  | Nine Months Ended September 30, 2018 Net Income | Diluted EPS | 2017 Net Income | Diluted EPS |
| --- | ---: | ---: | ---: | ---: |
| **Net Income Attributable to the Company as Reported** | **$85.8** | **$3.68** | **$81.7** | **$3.50** |
| Deferred Compensation (Income) Expense (including related investment activity) | 3.5 | 0.15 | 1.6 | 0.07 |
| Business Restructuring | 2.3 | 0.10 | 1.8 | 0.08 |
| Cumulative Tax Effect on Above Adjustment Items | (1.5) | (0.07) | (1.1) | (0.05) |
| Adjusted Net Income | $90.1 | $3.86 | $84.0 | $3.60 |

The Company believes that certain non-GAAP measures, when presented in conjunction with comparable GAAP measures, are useful for evaluating the Company’s operating performance and provide better clarity on the impact of non-operational items. Internally, the Company uses this non-GAAP information as an indicator of business performance and evaluates management’s effectiveness with specific reference to these indicators. These measures should be considered in addition to, not a substitute for or superior to, measures of financial performance prepared in accordance with GAAP. The cumulative tax effect was calculated using the statutory tax rates for the jurisdictions in which the noted transactions occurred.

#### RECONCILIATION OF NON-GAAP NET DEBT

Management uses the non-GAAP net debt metric to gain a more complete picture of the Company’s overall liquidity, financial flexibility and leverage level. This adjusted measure should be considered supplemental to and not a substitute for financial information prepared in accordance with GAAP. The Company's definition of this adjusted measure may differ from similarly titled measures used by other entities.

*(In millions)*

|  | June 30, 2018 | December 31, 2017 |
| --- | ---: | ---: |
| Current Maturities of Long-Term Debt as Reported | $24.3 | $22.5 |
| Long-Term Debt as Reported | 262.5 | 268.3 |
| Total Debt as Reported | 286.8 | 290.8 |
| Less Cash and Cash Equivalents as Reported | (256.7) | (298.9) |
| Net Debt | $30.1 | $(8.1) |

39

## Controls and procedures

As filed, 1,297 characters.

a. Evaluation of Disclosure Controls and Procedures

We have conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, as of September 30, 2018. Based on this evaluation of our disclosure controls and procedures, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of September 30, 2018, such that the information required to be disclosed in our Securities and Exchange Commission reports is recorded, processed, summarized and reported within the time periods specified by the rules and forms of the Exchange Act and is accumulated and communicated to management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosures.

b. Changes in Internal Control Over Financial Reporting

There were no changes in the Company’s internal controls over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that occurred during the quarter ended September 30, 2018, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Filed Nov 1, 2018.
Source: SEC EDGAR, the filing index for accession 0001564590-18-026046. Last ingested by Listed: Nov 10, 2026, 21:16 ET. No prices; not investment advice.
